Airiver Medical Receives IDE Approval from the FDA for Pivotal Clinical Study of the Airiver Pulmonary Drug Coated Balloon to Treat Benign Central Airway Stenosis

The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the respiratory tract with drug delivery designed to maintain symptom relief